Complete Mobile Drug Testing Franchise Cost, Revenue & Review 2026
Data from FDD filing
Analysis by FranchiseVerdict Research · Methodology
Complete Mobile Drug Testing is a healthcare services franchise providing mobile drug testing, DNA testing, and background checks. Franchisees run mobile operations, managing testing, collections, and accounts.
FranchiseVerdict summary · 2026
A Complete Mobile Drug Testing franchise requires a total initial investment of $68K – $288K, including a $55K – $215K franchise fee and an ongoing 10.0% royalty[2]. Per the 2026 FDD, average unit revenue was $889K[2]. FranchiseVerdict grade: C (Average), an editorial assessment, not investment advice. Run a live ROI scan →
Data last verified · figures per the 2026 FDD issuance
Overview
- Investment
- $68K – $288K
- 10th pct Healthcare
- Avg gross sales
- $889K
- Company-owned onlyn=116th pct Healthcare
- Royalty
- 10.0%
- 55th pct Healthcare
- Units
- 1
- 1st pct Healthcare
- SBA charge-off
- N/A
Quick verdict · Healthcare · color = vs category peers
Green = favorable by >10% vs Healthcare avg · No shading = within ±10% · Red = unfavorable by >10% · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Bottom line
- COSTTotal investment $68K – $288K including a $55K franchise fee, 10.0% ongoing royalty.
- RETURNSAverage unit revenue of $889K/year (median $889K) (company-owned outlets only - not franchisee performance). Estimated payback in 0.5 years.
- RISKVerdict C (Average), verdict score 43/100 (higher is better).
- FLAGRevenue data based on only 1 reporting unit. Treat as directional, not definitive. Ask franchisees directly for current unit economics.
Item 1 · who you're contracting with
The Franchisor
Corporate structure & franchisor financials
- Legal entity
- Complete Mobile Drug Testing Franchise LLC
- Parent company
- None
- Predecessor
- None
- Prior franchisor entity
- CEO title
- Founder and Chief Executive Officer
- Milka Krecak
- Incorporated in
- Wisconsin
- HQ
- 4805 S. 74th St., Suite B, Greenfield, WI 53220
Affiliated brands
- Complete Mobile Drug Testing
Other brands the franchisor or its parent operates (Item 1).
Overview
About
- CEO
- Milka Krecak
- Headquarters
- WI
- Founded
- 2011
- FDD year
- 2026
- States available
- 1
Can you afford it, and what does the money buy?
Entry cost runs 57% below the typical healthcare franchise.
Source: FDD 2026 · Items 5–7
Full Item 7 breakdown17 line items
Initial investment breakdown
| Line item | Low | High | |
|---|---|---|---|
| Initial Franchise Feenot refundable | $50K | $50K | |
| Rent and Deposit | $1K | $6K | |
| Utilities | $500 | $3K | |
| Leasehold Improvementsnot refundable | $500 | $5K | |
| Market Introduction Programnot refundable | $3K | $5K | |
| Furniture, Fixtures, and Equipmentnot refundable | $7K | $27K | |
| Computer Systemsnot refundable | $3K | $5K | |
| Insurance (3 months)not refundable | $800 | $2K | |
| Vehiclenot refundable | $0 | $4K | |
| Signagenot refundable | $100 | $500 | |
| Office Expensesnot refundable | $1K | $3K | |
| Inventorynot refundable | $700 | $3K | |
| Licenses and Permitsnot refundable | $150 | $250 | |
| Travel, lodging and meals for initial trainingnot refundable | $700 | $3K | |
| Additional funds (for first 3 months)not refundable | $5K | $8K | |
| Additional initial franchise fees (MUDA)not refundable | $80K | $160K | |
| Business planning and miscellaneous expenses (MUDA)not refundable | $1K | $5K | |
| Total initial investment | $153K | $288K |
Line items extracted from FDD Item 7. Ranges reflect the franchisor's stated low and high per line. Total is the sum of line-item lows / highs — actual costs may fall outside this range depending on market and build-out scope.
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $68K – $288K
- Top 40% of category vs category
- Liquid capital req'd
- $5K – $8K
- Top 40% of category vs category
- Franchise fee
- $55K – $215K
- Middle of category vs category
- Royalty
- 10.0%
- percentage · typical 6–8%
- Ad fund
- 0.0%
- typical 3–5%
- Total fee load
- 12.0%
- vs 9–13% typical
- Payback period
- 0.5 yrs
- From FDD / Item 19
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Royalty | 10.0% of gross sales |
| Marketing / ad fund | 0.0% of gross sales |
| Technology fee | $250 |
| Training fee | $500 |
| Transfer fee | $15K |
| Renewal fee | $5K |
| Inventory (initial) | $700 – $3K |
| Total fee load | 12.0% of rev |
What do units actually make?
Average unit sales run 37% below the healthcare norm.
Company-owned outlets only - not franchisee performance
Based on a single reporting unit - not a system average
Source: FDD 2026 · Item 19
Single-unit · estimated
Returns at a glance
Indicative numbers using FDD Item 7 / Item 19 inputs and category-benchmarked cost ratios. Full single-unit, 25-unit portfolio, and LBO models (with every input editable to stress-test your own scenario) live on the financials page.
Store EBITDA · annual
$133K
15.0% margin
Unlevered ROIC
72%
EBITDA / total invested capital
Payback
17 mo
cash-on-cash, unlevered
ROI & LBO modelsSingle-unit · 25-unit portfolio · editable
FDD-reported earnings vs. model
The FDD reports $394K as Net Profit. Our model estimates $133K SLEBITDA from the same revenue using category-average cost assumptions. These numbers differ because Net Profit deducts different expense categories than our model.
What one unit earns on your invested capital
Model A · Single-Unit Return
Computes unlevered return on invested capital (ROIC) for a single franchise unit. The target band for an attractive franchise is 30–60% ROIC. Below that and a passive index fund likely outperforms; above that and the franchisor has pricing power you're subsidizing.
Note: Item 19 revenue is what the franchisor discloses. It's the top line only. Operating costs below are category estimates. Override them to match your real lease quote, labor market, and build-out budget.
Returns model · single-unit ROIC
What would one Complete Mobile Drug Testing unit return on the cash you put in?
Unlevered ROIC · per unit
Estimated return on your total franchise investment, before any debt financing.
72%
Above the 30–60% band. Verify revenue is per-unit average
What 25 units return when you use SBA financing
Model B · Return on Equity: Debt-Financed Acquisition
Models a 25-unit portfolio acquisition financed with an SBA 7(a) loan. Shows equity IRR (your return on cash invested), DSCR (how safely the cash flow covers debt service), and the capital stack (SBA + seller + equity breakdown).
This is the “search fund” or “entrepreneurship through acquisition” scenario: you buy an existing multi-unit operator, use leverage to amplify returns, and either operate or hire management. The 25-unit size is the typical minimum for an SBA-backed franchise portfolio acquisition to pencil as a full-time income.
What “return on equity” means here: if you put in $500K of your own cash and the business generates enough EBITDA to pay down debt and grow, your equity IRR is the annual return on that $500K, including the value created when you eventually sell. Target IRR for a search fund is typically 25–35%.
Levered LBO scenario · Yale Crease Capital framing
What would 25 Complete Mobile Drug Testing units return on equity?
Equity IRR · 5-yr
49.9%
7.57× MOIC
Year-1 DSCR
1.88×
EBITDA ÷ debt service
Equity required
$1.4M
on $7.1M purchase
Total debt
$5.7M
SBA $3.6M + senior + seller note
These models are for research and scenario planning only. Not investment advice. Actual results depend on your specific location, management, and market conditions. Consult a franchise attorney and accountant before signing any franchise agreement.
Item 19 · Source: 2026 FDD
Financial Performance
Company-owned outlets only - not franchisee performance
Based on a single reporting unit - not a system average
- Avg gross sales
- $889K
- Per unit, per year
- Median gross sales
- $889K
- Avg net profit
- $394K
- Reported as Net Profit in FDD Item 19
Gross sales are revenue before expenses — not profit. Actual owner earnings depend on rent, labor, royalties, marketing fees, and debt service.
- Item 19 type
- historic
- Sample size
- 1
- vs category median 20 · small
- Reported figure
- $889K
- A single outlet — not a range
- Transparency tier
- limited
- Categorical assessment of disclosure depth
- Reporting year
- 2025
- Fiscal year the figures cover
- Source filing
- FDD 2026
- Disclosed in the 2026 filing, covering 2025
- Transparency
- 9 / 10
- vs category median 3 / 10 · above
Compared against 162 Healthcare brands
Revenue is 5.0x the investment midpoint. At typical franchise margins, this suggests a payback under 3 years.
Operator outlook
What the numbers say
Data-driven interpretation of this brand's financial disclosures, fee structure, and system trajectory.
Unit economics
Average unit generates $889K/year in gross sales. Revenue-to-investment ratio: 5.0x. Company-owned outlets only - not franchisee performance.
Fee burden
Total ongoing fee load of 12.0% — above the Healthcare average of 8.8%.
Disclosure
Transparency score 9/10 — this franchisor discloses detailed breakdowns (quartiles, segments, or cohort data). Buyers can model unit economics with higher confidence. Sample size of 1 unit — treat as directional only.
Source: FDD Item 19 financial performance representations and publicly filed FDD data. Past performance is not indicative of future results. Verify all figures with the franchisor and current franchisees before making any investment decision.
vs Healthcare averages
How Complete Mobile Drug Testing Compares
Is the system healthy?
Source: FDD 2026 · Item 20
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 1
- Opened
- 0
- Last reporting year
- Closed
- 0
- Terminated
- 0
- Franchisor ended the franchise (per Item 20)
- Non-renewed
- 0
- Term expired, not renewed (per Item 20)
- Turnover rate
- 0.0%
- Company-owned
- 1
- Corporate units in the system
- % franchised
- 0%
- vs corporate-owned
3-year detail · Item 20
- Opened (3yr)
- 0
- Closed (3yr)
- 0
- Terminated (3yr)
- 0
- Non-renewed (3yr)
- 0
- Transfers (3yr)
- 0
- Reacquired (3yr)
- 0
- Franchisor bought back
- Projected new
- 1
- Franchisor's next-year forecast
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 12 · 1 state reported
The Territory Map
FDD Item 12 reports the state count, but the specific list isn't in our current data. The map will appear once we re-extract from the FDD or enough franchisee contacts are available.
1
states with franchisees (per FDD Item 12)
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
No SBA loan data available for this brand.
What could kill this investment?
Source: SBA 7(a) FOIA · FDD Items 3, 21
Risk analysis
FranchiseVerdict rating + FDD Items 3, 4, 8, 16, 21
Risk & Legal
Single-unit franchise with going concern issues, unverified financial claims, and unclear growth trajectory presents significant execution and support risk despite reasonable unit economics.
Litigation (Item 3)
No litigation is required to be disclosed in this Item.
Bankruptcy (Item 4)
None disclosed
Audited financials (Item 21)
Yes
Supplier relationship · Items 8 & 16
- Franchisor sells you products: No
- Kickbacks from required suppliers: No
- Must buy proprietary products: No
- Restricted to system-approved products: No
- Can negotiate own supplier terms: No
Score breakdown · what drove the 43 / 100 verdict
- 01MINOROnly 1 unit in system with unknown growth trajectory indicates either brand-new or stagnant franchise
- 02HIGHGoing Concern flag is FALSE — suggests potential financial instability or undisclosed operational issues
- 03MINOR10% royalty on adjusted gross sales creates ambiguity on what deductions apply before royalty calculation
- 04MINORProtected territory claim unverified with only one franchisee — unclear how franchisor enforces or defines territory boundaries
Severity inferred from the FDD text · not a regulatory classification
What are you signing up for?
Ongoing fees run about 12.0% of sales (royalty + ad fund), before rent and labor.
Source: FDD 2026 · Items 11, 12, 17
FDD Items 12, 15, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 10 years |
|---|---|
| Renewal term | 5 years |
| Allowed renewalsℹ | 2 |
| Territory type | exclusive |
| Protected territory | Yes |
| Exclusive territoryℹ | Yes |
| Territory population | 250,000 |
| Online sales rights | Restricted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Optional |
| Non-compete (years)ℹ | 2 years |
| Non-compete (miles)ℹ | 5 mi |
| Right of first refusalℹ | Yes |
| RoFR response window | 30 days |
| Transfer requires consent | Yes |
| Termination notice | 30 days |
| Termination groundsℹ | 1 |
| Curable defaultsℹ | 2 |
| Mandatory arbitration | Yes |
| Arbitration location | Greenfield, Wisconsin |
| Jury trial waiver | No |
| Governing law | Wisconsin |
| Litigation count | 0 |
View Item 3 litigation summary
No litigation is required to be disclosed in this Item.
Items 10, 11
Training & Operations
- Classroom training
- 15 hrs
- On-the-job training
- 21 hrs
- Training location
- Greenfield, Wisconsin
- Ongoing training
- Optional
- Time to open
- 4 mo
- From signing to launch
- Site selection
- franchisee
- Franchisor financing
- Not offered
- Item 10
- POS system
- Electronic Merchant Systems
- Operating tech stack
Items 5 & 11
Franchisor Support
Technology: Electronic Merchant Systems
Item 20 · call current owners
Franchisee Contacts
1 owners to call
Name · phone · city · state. Extracted from FDD Item 20
FDD download
Complete Mobile Drug Testing · FDD (2026) PDF
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a Complete Mobile Drug Testing franchise?
The total investment to open a Complete Mobile Drug Testing franchise ranges from $68K – $288K, with an initial franchise fee of $55K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do Complete Mobile Drug Testing franchise owners earn?
According to Item 19 of the Complete Mobile Drug Testing FDD, the average gross sales per unit is $889K. The median is $889K. Important context: Company-owned outlets only - not franchisee performance; Based on a single reporting unit - not a system average. Note: this is gross revenue, not profit. Actual owner earnings vary based on location, operating costs, and management.
What is Item 19 in the Complete Mobile Drug Testing FDD?
The FDD section where a franchisor may disclose financial performance of its outlets. Disclosure is optional and formats vary; figures are typically gross sales, which is revenue before expenses, not profit. FranchiseVerdict extracts these figures directly from the Complete Mobile Drug Testing FDD and qualifies whose outlets they describe.
What is Complete Mobile Drug Testing's franchise failure rate?
SBA 7(a) loan charge-off data is not available for Complete Mobile Drug Testing (fewer than 10 loans on file). Charge-off rates are one way to gauge franchise risk, but not all franchise loans go through the SBA program. We recommend reviewing turnover and closure data in the FDD and speaking with current franchisees.
How many Complete Mobile Drug Testing franchise locations are there?
As of their most recent FDD filing, Complete Mobile Drug Testing has 1 total units in the United States, including 0 franchised units and 1 company-owned units.
Is Complete Mobile Drug Testing a good franchise to buy?
FranchiseVerdict rates Complete Mobile Drug Testing as a C-grade franchise with a verdict score of 43 out of 100 (higher is better), based on our analysis of investment costs, revenue data, SBA loan performance, and growth trends. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent Complete Mobile Drug Testing, you can request corrections or provide updated information.
Other Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.